World Orphan Drug Congress, Europe

Slated for November 15 to 18, 2021, the World Orphan Drug Congress presents one of Europe’s most exciting events offering conference topics in cell and gene therapy, genetic testing, gene editing, partnering and investment, global market access, patient advocacy, orphan drug policy, clinical trials and other exciting subjects.

The World Orphan Drug Congress is an award-winning event with an exhibition that has grown to become the largest and most established orphan drugs & rare diseases meeting of its kind across the globe.

Now recognized as the largest and most established multi-stakeholder rare disease meeting, World Orphan Drug Congress is proud to deliver another outstanding speaker line-up and a content-filled agenda that represents the whole orphan drug landscape.

With 500+ potential customers in attendance, there will be opportunities to find contacts who need to find solutions to challenges around the political, commercial, and scientific issues in manufacturing, clinical trials, strategy, regulation & policy, Market Access & Pricing, Science & Strategy, Pitch & Partner and Precision Medicine.

Now in its 12th annual edition, the World Orphan Drug Congress Europe, together with the co-located Cell & Gene Therapy Congress, will continue to bring experts from the whole value chain under one roof, where you get to meet decision-makers in the areas that are most applicable for your business offering.  For more information and registration follow this link.

© 2021, Pituitary World News. All rights reserved.

LEAVE A REPLY

Please enter your comment!
Please enter your name here